11月 2025
- 首頁
- Teva Pharmaceuticals
11月 2025Teva Pharmaceuticals的市場佔有率分析
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva Pharmaceuticals(包含公司地區)
查看更多網站流量與參與度資訊- tevausa.com
Teva Pharmaceuticals截至 11月 2025 的總收入為 > 1B
Teva Pharmaceuticals 熱門網域產生的總收入
Teva Pharmaceuticals 熱門網域 3 年內的總收入
Teva Pharmaceuticals 熱門網域的總收入
11月 2025Teva Pharmaceuticals的股票價格
Teva Pharmaceuticals 股票交易代碼 #TEVA。以下是截至 11月 2025Teva Pharmaceuticals 過去 12 個月的股票績效
Teva Pharmaceuticals的熱門網域總造訪量
了解Teva Pharmaceuticals市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Teva Pharmaceuticals的熱門網域平均造訪時長
分析Teva Pharmaceuticals參與度指標。
過去 3 個月平均造訪時長
子公司細目
Teva Pharmaceuticals的熱門網域平均頁面瀏覽量
了解Teva Pharmaceuticals如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Teva Pharmaceuticals
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Teva Pharmaceuticals USA Inc has issues with recall of 580,844 bottles of Prazosin Hydrochloride capsules.New Jersey-based Teva Pharmaceuticals USA Inc has issued a voluntary recall of 580,844 bottles of Prazosin Hydrochloride capsules over the presence of N-nitroso Prazosin impurity C
10月 31, 2025閱讀更多
新聞Teva Pharmaceuticals USA Inc decreases headcount by 2893.In what's sure to be unwelcome news, May's layoffs have already surpassed April's with Teva Pharmaceuticals cutting 2,893 employees worldwide.
5月 9, 2025閱讀更多
新聞Celltrion, Inc. partners with Teva Pharmaceuticals USA Inc.Strategic Partnerships: Celltrion partnered with Teva Pharmaceuticals for the U.S. launch, leveraging Teva's established distribution network to increase market penetration and awareness among healthcare providers.
10月 25, 2024閱讀更多
查看所有Teva Pharmaceuticals信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。